For 25 years, Steven Halpern, editor of TheStockAdvisors.com, has surveyed the leading financial newsletter advisors asking for their favorite stocks for the coming year. This article is one of 100+ ideas in the Best Stocks for 2008 report.

"Beijing-based biotech firm China Medical Technologies (NASDAQ: CMED) offers a unique product in a booming area -- non-invasive medical devices. CMED sells the High-Intensity Focused Ultrasound (HIFU) therapy system," says Mark Skousen, editor of Forecasts & Strategies and author of the just-released best seller, Investing in One Lesson.

"This system uses an ultrasound-guided ablation technique that is used for the non-invasive treatment of liver, breast, and kidney tumors; solid tumors in the pelvic cavity or bone; and tumors in the four limbs or superficial tissues. The HIFU system has been wildly successful in China, and now is expanding elsewhere.

"Countries such as Japan and Korea have approved its high-intensity focused ultrasound (HIFU) tumor therapy systems for the treatment of liver, pancreatic, and uterine cancer.

"China Medical is really taking off with rising earnings growth projected to occur in 2008, 2009 and 2010, amid further acceptance of the HIFU technology worldwide. Acceptance of that technology will drive international revenues, starting in Korea, Europe, Japan, and the United States.

"China Medical also recently purchased Fluorescent in Situ Hybridization (FISH) technology, which involves a DNA probe with fluorescent dye so that it can be seen with a microscope. Profit margins on FISH technology are roughly 80%.

"Revenues and earnings are growing at an outstanding 40-50% a year. China Medical recently reported a great earnings report: Net revenues jumped 64% to $28.7 million, and earnings climbed 39% to $14 million. I believe China Medical could sell for $100 a share within 1-2 years. Keep buying."